JS
James Shin Deutsche Bank Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$652B
| $727.21 | $900 |
24%
upside
| Buy |
11 Aug ‘25
27 days ago |
|
2
Immatics
IMTX
$761M
| $6.26 | $10 |
60%
upside
| Buy |
28 May ‘25
3 months ago |
|
3
Gilead Sciences
GILD
$143B
| $115.05 | $120 |
4%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
4
Merck
MRK
$212B
| $84.71 | $105 |
24%
upside
| Hold |
18 Feb ‘25
6 months ago |
|
5
Amgen
AMGN
$153B
| $283.64 | $305 |
8%
upside
| Hold |
7 Aug ‘24
1 year ago |
|
6
Incyte
INCY
$16.9B
| $86.64 | $60 |
31%
downside
| Hold |
1 Aug ‘24
1 year ago |
|
7
Bristol-Myers Squibb
BMY
$96B
| $47.14 | $45 |
5%
downside
| Hold |
23 Jul ‘24
1 year ago |
|
8
Legend Biotech
LEGN
$6.66B
| $36.08 | $60 |
66%
upside
| Buy |
23 May ‘24
1 year ago |
|
9
AbbVie
ABBV
$375B
| $212.56 | $150 |
29%
downside
| Hold |
9 Nov ‘23
1 year ago |
|
10
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $800 |
40%
upside
| Hold |
9 Nov ‘23
1 year ago |
|
|
AUTL
11
Autolus Therapeutics
AUTL
$389M
| $1.46 | $10 |
585%
upside
| Buy |
9 Nov ‘23
1 year ago |
|
12
Sutro Biopharma
STRO
$89.9M
| $1.06 | $12 |
1,032%
upside
| Buy |
9 Nov ‘23
1 year ago |
|